Zendure, a global leader in plug-and-play home energy management, has signed a Memorandum of Understanding with Dutch energy supplier Sunergy to enhance smart energy storage solutions for homes in the Netherlands. This partnership aims to leverage dynamic energy pricing, which links electricity costs to real-time market fluctuations, helping households optimize energy use, reduce costs, and maximize solar energy benefits ahead of regulatory changes in 2027 and 2029. Zendure's SolarFlow 2400 AC+ system, integrated with AI-driven energy management, will be combined with Sunergy's local market expertise to offer scalable, intelligent storage solutions. The collaboration also includes local support from Natec to improve logistics and service delivery, marking Zendure's shift from hardware provider to comprehensive energy partner in the Dutch market.
After the largest XRP inflow of the year, with 22.8 million tokens moved to exchanges on May 28, a significant outflow of 25.24 million XRP occurred between May 29 and 30. This rapid exit followed traders selling at a local price bottom, causing many...
Booz Allen Hamilton, a leading government consulting firm, is currently trading below its historical valuation multiples, offering a compelling buy opportunity. The company has a 14-year streak of dividend growth, a strong dividend safety profile, an...
Shiba Inu (SHIB) exchange reserves are close to falling below the 80 trillion token mark for the first time in a long time, a key psychological and structural threshold. This decline suggests investors are moving SHIB off exchanges into private walle...
The United States, United Kingdom, and Australia have announced a joint initiative under the AUKUS alliance to develop advanced underwater drone technology by 2027. This program aims to protect critical subsea internet cables, which have been increas...
Novartis announced that Pluvicto combined with standard care significantly improves radiographic progression-free survival (rPFS) in metastatic hormone-sensitive prostate cancer (mHSPC) patients, regardless of disease volume or presentation. The PSMA...
